Product Information

PIOGLITAZONE HCL 15 MG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0647 per EA under NDC 33342005415. Its NADAC has been published 610 times since Jun 18, 2014.

FDA first approved this application on Feb 6, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 15 MG TABLET

Pioglitazone
$0.0647per EA

Strength

15 mg/1

NDC

33342005415

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202467

FDA Approved

2/6/2013

TE Code

AB

On Market Since

2/14/2013

Pharmacological Classes

PPAR alpha
PPAR gamma
Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor Activity
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 15 MG TABLET has been published 610 times since Jun 18, 2014, and over the history we have for it it has declined 63.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0647 per EA
All-time high$0.1772 (Jul 16, 2014)
All-time low$0.0587 (Nov 20, 2024)
52-week high$0.0727
52-week low$0.0647
Median price$0.0925
Average price$0.1013
Largest weekly change-25.8% (Nov 20, 2024)
Weeks tracked610
Tracking sinceJun 18, 2014

Price History

1W

-2.2%

1M

-2.2%

3M

-7.7%

6M

-5.6%

1Y

-11.0%

3Y

-23.4%

5Y

-42.1%

All

-63.5%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 15 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 15 MG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0647 per EA (NDC 33342005415), effective Aug 19, 2026.

How has the price of PIOGLITAZONE HCL 15 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has declined 63.5%. It has been tracked across 610 weekly CMS publications since Jun 18, 2014.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 15 MG TABLET?

Since Jun 18, 2014, the NADAC for PIOGLITAZONE HCL 15 MG TABLET has ranged from a low of $0.0587 (Nov 20, 2024) to a high of $0.1772 (Jul 16, 2014), with a median of $0.0925 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 15 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PIOGLITAZONE HCL 15 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures PIOGLITAZONE HCL 15 MG TABLET?

PIOGLITAZONE HCL 15 MG TABLET (NDC 33342005415) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.